{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:37:31Z","timestamp":1777603051025,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T00:00:00Z","timestamp":1494460800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s10072-017-2993-7","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T16:32:21Z","timestamp":1494520341000},"page":"1137-1141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Phenytoin: neuroprotection or neurotoxicity?"],"prefix":"10.1007","volume":"38","author":[{"given":"Jan M.","family":"Keppel Hesselink","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Kopsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,11]]},"reference":[{"issue":"3","key":"2993_CR1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1474-4422(16)00004-1","volume":"15","author":"R Raftopoulos","year":"2016","unstructured":"Raftopoulos R, Hickman SJ, Toosy A, Sharrack B, Mallik S, Paling D, Altmann DR, Yiannakas MC, Malladi P, Sheridan R, Sarrigiannis PG, Hoggard N, Koltzenburg M, Gandini Wheeler-Kingshott CA, Schmierer K, Giovannoni G, Miller DH, Kapoor R (2016) Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial. Lancet Neurol 15(3):259\u2013269","journal-title":"Lancet Neurol"},{"issue":"11 Suppl","key":"2993_CR2","first-page":"III47","volume":"21","author":"PA Boxer","year":"1990","unstructured":"Boxer PA, Cordon JJ, Mann ME, Rodolosi LC, Vartanian MG, Rock DM, Taylor CP, Marcoux FW (1990) Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in rat. Stroke 21(11 Suppl):III47\u2013III51","journal-title":"Stroke"},{"issue":"1","key":"2993_CR3","first-page":"89","volume":"7","author":"V Lakics","year":"1995","unstructured":"Lakics V, Molnar P, Erdo SL (1995) Protection against veratridine toxicity in rat cortical cultures: relationship to sodium channel blockade. Neuroreport 7(1):89\u201392","journal-title":"Neuroreport"},{"issue":"3","key":"2993_CR4","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-3565(25)39449-8","volume":"266","author":"R Fern","year":"1993","unstructured":"Fern R, Ransom BR, Stys PK, Waxman SG (1993) Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam. J Pharmacol Exp Ther 266(3):1549\u20131555","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"2993_CR5","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1152\/jn.00434.2003","volume":"90","author":"AC Lo","year":"2003","unstructured":"Lo AC, Saab CY, Black JA, Waxman SG (2003) Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J Neurophysiol 90(5):3566\u20133571","journal-title":"J Neurophysiol"},{"key":"2993_CR6","doi-asserted-by":"crossref","unstructured":"Zeng Z, Hill-Yardin EL, Williams DA, O'Brien TJ, Serelis A, French CR (2016) The Effect of Phenytoin on Sodium Conductances in Rat Hippocampal CA1 Pyramidal Neurons. J Neurophysiol 3 (01060)","DOI":"10.1152\/jn.01060.2015"},{"issue":"14","key":"2993_CR7","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/jama.1942.02830140039012","volume":"118","author":"I Finkelman","year":"1942","unstructured":"Finkelman I, Arieff AJ (1942) Untoward effects of phenytoin sodium in epilepsy. J Am Med Assoc 118(14):1209\u20131212. doi: 10.1001\/jama.1942.02830140039012","journal-title":"J Am Med Assoc"},{"issue":"1","key":"2993_CR8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0013-4694(49)90161-3","volume":"1","author":"JE Toman","year":"1949","unstructured":"Toman JE (1949) The neuropharmacology of antiepileptics. Electroencephalogr Clin Neurophysiol 1(1):33\u201344","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"2","key":"2993_CR9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1212\/WNL.8.2.140","volume":"8","author":"F Morrell","year":"1958","unstructured":"Morrell F, Bradley W, Ptashne M (1958) Effect of diphenylhydantoin on peripheral nerve. Neurology 8(2):140\u2013144","journal-title":"Neurology"},{"issue":"12","key":"2993_CR10","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1212\/WNL.16.12.1217","volume":"16","author":"J Brumlik","year":"1966","unstructured":"Brumlik J, Moretti L (1966) The effect of diphenylhydantoin on nerve conduction velocity. Neurology 16(12):1217\u20131218","journal-title":"Neurology"},{"issue":"1","key":"2993_CR11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archneur.1968.00470310083007","volume":"18","author":"RE Lovelace","year":"1968","unstructured":"Lovelace RE, Horwitz SJ (1968) Peripheral neuropathy in long-term diphenylhydantoin therapy. Arch Neurol 18(1):69\u201377","journal-title":"Arch Neurol"},{"issue":"3","key":"2993_CR12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0404.1971.tb07482.x","volume":"47","author":"E Birket-Smith","year":"1971","unstructured":"Birket-Smith E, Krogh E (1971) Motor nerve conduction velocity during diphenylhydantoin intoxication. Acta Neurol Scand 47(3):265\u2013271","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"2993_CR13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1212\/WNL.24.5.411","volume":"24","author":"AA Eisen","year":"1974","unstructured":"Eisen AA, Woods JF, Sherwin AL (1974) Peripheral nerve function in long-term therapy with diphenylhydantoin. A clinical and electrophysiologic correlation. Neurology 24(5):411\u2013417","journal-title":"Neurology"},{"issue":"2","key":"2993_CR14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1528-1157.1974.tb04938.x","volume":"15","author":"O Encinoza","year":"1974","unstructured":"Encinoza O (1974) Nerve conduction velocity in patients on long-term diphenylhydantoin therapy. Epilepsia 15(2):147\u2013154","journal-title":"Epilepsia"},{"issue":"6164","key":"2993_CR15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/bmj.1.6164.663","volume":"1","author":"Z Argov","year":"1979","unstructured":"Argov Z, Mastaglia FL (1979) Drug-induced peripheral neuropathies. Br Med J 1(6164):663\u2013666","journal-title":"Br Med J"},{"issue":"7816","key":"2993_CR16","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(73)91690-5","volume":"1","author":"EH Reynolds","year":"1973","unstructured":"Reynolds EH (1973) Anticonvulsants, folic acid, and epilepsy. Lancet 1(7816):1376\u20131378","journal-title":"Lancet"},{"issue":"3","key":"2993_CR17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-510X(80)90104-5","volume":"48","author":"A Martinez Figueroa","year":"1980","unstructured":"Martinez Figueroa A, Johnson RH, Lambie DG, Shakir RA (1980) The role of folate deficiency in the development of peripheral neuropathy caused by anticonvulsants. J Neurol Sci 48(3):315\u2013323","journal-title":"J Neurol Sci"},{"issue":"7542","key":"2993_CR18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(68)92832-8","volume":"1","author":"SJ Horwitz","year":"1968","unstructured":"Horwitz SJ, Klipstein FA, Lovelace RE (1968) Relation of abnormal folate metabolism to neuropathy developing during anticonvulsant drug therapy. Lancet 1(7542):563\u2013565","journal-title":"Lancet"},{"issue":"4","key":"2993_CR19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0387-7604(81)80066-6","volume":"3","author":"Y Mochizuki","year":"1981","unstructured":"Mochizuki Y, Suyehiro Y, Tanizawa A, Ohkubo H, Motomura T (1981) Peripheral neuropathy in children on long-term phenytoin therapy. Brain and Development 3(4):375\u2013383","journal-title":"Brain and Development"},{"issue":"7","key":"2993_CR20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jnnp.45.7.620","volume":"45","author":"SD Shorvon","year":"1982","unstructured":"Shorvon SD, Reynolds EH (1982) Anticonvulsant peripheral neuropathy: a clinical and electrophysiological study of patients on single drug treatment with phenytoin, carbamazepine or barbiturates. J Neurol Neurosurg Psychiatry 45(7):620\u2013626","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 12","key":"2993_CR21","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1093\/brain\/awl216","volume":"129","author":"JA Black","year":"2006","unstructured":"Black JA, Liu S, Hains BC, Saab CY, Waxman SG (2006) Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE. Brain 129(Pt 12):3196\u20133208","journal-title":"Brain"},{"issue":"1\u20132","key":"2993_CR22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jns.2005.03.003","volume":"233","author":"DA Bechtold","year":"2005","unstructured":"Bechtold DA, Smith KJ (2005) Sodium-mediated axonal degeneration in inflammatory demyelinating disease. J Neurol Sci 233(1\u20132):27\u201335","journal-title":"J Neurol Sci"},{"issue":"2","key":"2993_CR23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/glia.20112","volume":"49","author":"MJ Craner","year":"2005","unstructured":"Craner MJ, Damarjian TG, Liu S, Hains BC, Lo AC, Black JA, Newcombe J, Cuzner ML, Waxman SG (2005) Sodium channels contribute to microglia\/macrophage activation and function in EAE and MS. Glia 49(2):220\u2013229","journal-title":"Glia"},{"issue":"29","key":"2993_CR24","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1055\/s-0028-1106417","volume":"100","author":"O Meienberg","year":"1975","unstructured":"Meienberg O, Bajc O (1975) Acute polyneuropathy caused by diphenylhydantoin intoxication (author\u2019s transl). Dtsch Med Wochenschr 100(29):1532\u20131534","journal-title":"Dtsch Med Wochenschr"},{"issue":"3","key":"2993_CR25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archneur.1977.00500150075015","volume":"34","author":"BH Dobkin","year":"1977","unstructured":"Dobkin BH (1977) Reversible subacute peripheral neuropathy induced by phenytoin. Arch Neurol 34(3):189\u2013190","journal-title":"Arch Neurol"},{"issue":"2","key":"2993_CR26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ana.410190209","volume":"19","author":"JA Ramirez","year":"1986","unstructured":"Ramirez JA, Mendell JR, Warmolts JR, Griggs RC (1986) Phenytoin neuropathy: structural changes in the sural nerve. Ann Neurol 19(2):162\u2013167","journal-title":"Ann Neurol"},{"issue":"2","key":"2993_CR27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1528-1157.1993.tb02418.x","volume":"34","author":"A Bono","year":"1993","unstructured":"Bono A, Beghi E, Bogliun G, Cavaletti G, Curto N, Marzorati L, Frattola L (1993) Antiepileptic drugs and peripheral nerve function: a multicenter screening investigation of 141 patients with chronic treatment. Collaborative group for the study of epilepsy. Epilepsia 34(2):323\u2013331","journal-title":"Epilepsia"},{"issue":"4","key":"2993_CR28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1528-1157.1999.tb00754.x","volume":"40","author":"H Yoshikawa","year":"1999","unstructured":"Yoshikawa H, Abe T, Oda Y (1999) Extremely acute phenytoin-induced peripheral neuropathy. Epilepsia 40(4):528\u2013529","journal-title":"Epilepsia"},{"issue":"4","key":"2993_CR29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1085-9489.2004.09408.x","volume":"9","author":"C Toth","year":"2004","unstructured":"Toth C (2004) Kotecha SA prolonged and excessive phenytoin therapy leading to a severe and partially reversible polyneuropathy. J Peripher Nerv Syst 9(4):198\u2013199","journal-title":"J Peripher Nerv Syst"},{"issue":"16","key":"2993_CR30","first-page":"30042","volume":"24","author":"AM Mahon","year":"2016","unstructured":"Mahon AM (2016) Lacking the \u2018protective label\u2019 of diabetes: phenytoin-induced distal symmetrical peripheral neuropathy. A clinical case report. J Tissue Viability 24(16):30042\u201330040","journal-title":"J Tissue Viability"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-017-2993-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-2993-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-2993-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T12:58:25Z","timestamp":1750251505000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-017-2993-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["2993"],"URL":"https:\/\/doi.org\/10.1007\/s10072-017-2993-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,11]]}}}